Name: | SAMYANG BIOPHARM USA INC. |
Jurisdiction: | New York |
Legal type: | FOREIGN BUSINESS CORPORATION |
Status: | Inactive |
Date of registration: | 29 Jan 2009 (16 years ago) |
Entity Number: | 3768897 |
County: | New York |
Date of dissolution: | 17 Apr 2019 |
Place of Formation: | Delaware |
Address: | ONE KENDALL SQUARE, CAMBRIDGE, MA, United States, 02139 |
Address ZIP Code: | 02139 |
Principal Address: | 405 LEXINGTON AVE, 35TH FL, NEW YORK, NY, United States, 10174 |
Principal Address ZIP Code: | 10174 |
Name | Role | Address |
---|---|---|
THE CORPORATION | DOS Process Agent | ONE KENDALL SQUARE, CAMBRIDGE, MA, United States, 02139 |
Name | Role | Address |
---|---|---|
HAEJEONG AN | Chief Executive Officer | 405 LEXINGTON AVE, 35TH FL, NEW YORK, NY, United States, 10174 |
Start date | End date | Type | Value |
---|---|---|---|
2017-11-13 | 2019-04-17 | Address | 550 DURIE AVE #205, CLOSTER, NJ, 07624, USA (Type of address: Service of Process) |
2015-06-17 | 2017-11-13 | Address | 405 LEXINGTON AVE, 35TH FL, NEW YORK, NY, 10174, USA (Type of address: Service of Process) |
2011-01-25 | 2015-06-17 | Address | 405 LEXINGTON AVE, 35TH FL, NEW YORK, NY, 10174, USA (Type of address: Chief Executive Officer) |
2011-01-25 | 2015-06-17 | Address | 405 LEXINGTON AVE, 35TH FL, NEW YORK, NY, 10174, USA (Type of address: Service of Process) |
2009-01-29 | 2011-01-25 | Address | THE CHRYSLER BUILDING, 405 LEXINGTON AVENUE, 35TH FL., NEW YORK, NY, 10174, USA (Type of address: Service of Process) |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
190417000077 | 2019-04-17 | SURRENDER OF AUTHORITY | 2019-04-17 |
190214000242 | 2019-02-14 | CERTIFICATE OF AMENDMENT | 2019-02-14 |
171113006377 | 2017-11-13 | BIENNIAL STATEMENT | 2017-01-01 |
150617006066 | 2015-06-17 | BIENNIAL STATEMENT | 2015-01-01 |
130110006131 | 2013-01-10 | BIENNIAL STATEMENT | 2013-01-01 |
110125002290 | 2011-01-25 | BIENNIAL STATEMENT | 2011-01-01 |
090129000701 | 2009-01-29 | APPLICATION OF AUTHORITY | 2009-01-29 |
Date of last update: 08 Nov 2024
Sources: New York Secretary of State